Frontier Capital Management CO LLC Novo Cure LTD Transaction History

Frontier Capital Management CO LLC

$10.2 Billion
Q1 2024

A detailed history of Frontier Capital Management CO LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 921,116 shares of NVCR stock, worth $15.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

921,116

Previous 793,474 16.09%

Holding current value

$15.8 Million

Previous $11.8 Million 21.53%

% of portfolio

0.14%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $1.59 Million - $2.21 Million	127,642 Added 16.09%	921,116 $14.4 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $4.11 Million - $5.82 Million	369,037 Added 86.95%	793,474 $11.8 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $3.68 Million - $9.65 Million	227,942 Added 116.0%	424,437 $6.85 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $5.02 Million - $10.3 Million	-124,476 Reduced 38.78%	196,495 $8.15 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $1.2 Million - $2.52 Million	-21,239 Reduced 6.21%	320,971 $19.3 Million

Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $515,742 - $688,167	-8,061 Reduced 2.3%	342,210 $25.1 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $336,074 - $442,744	-4,943 Reduced 1.39%	350,271 $26.6 Million
Q2 2022 Jul 20, 2022	SELL	$56.6 - $89.9 $8.44 Million - $13.4 Million	-149,140 Reduced 29.57%	355,214 $24.7 Million
Q1 2022 Apr 14, 2022	BUY	$60.15 - $84.52 $4.27 Million - $6.01 Million	71,070 Added 16.4%	504,354 $41.8 Million
Q4 2021 Jan 19, 2022	BUY	$75.08 - $121.99 $15.5 Million - $25.2 Million	206,517 Added 91.07%	433,284 $32.5 Million
Q3 2021 Oct 19, 2021	SELL	$116.17 - $194.55 $15.4 Million - $25.8 Million	-132,499 Reduced 36.88%	226,767 $26.3 Million
Q2 2021 Aug 09, 2021	BUY	$130.4 - $225.58 $46.5 Million - $80.4 Million	356,364 Added 12279.94%	359,266 $79.7 Million
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $360,167 - $551,873	2,902 New	2,902 $384,000
Q4 2020 Jan 19, 2021	SELL	$112.16 - $174.14 $16.9 Million - $26.2 Million	-150,350 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $7.5 Million - $14.4 Million	129,123 Added 608.3%	150,350 $16.7 Million
Q2 2020 Jul 17, 2020	SELL	$57.2 - $74.41 $8.58 Million - $11.2 Million	-150,031 Reduced 87.61%	21,227 $1.26 Million
Q1 2020 Apr 16, 2020	BUY	$57.05 - $95.75 $7.54 Million - $12.7 Million	132,202 Added 338.49%	171,258 $11.5 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $815,433 - $1.12 Million	-11,939 Reduced 23.41%	39,056 $3.29 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $22 Million - $34.8 Million	-355,838 Reduced 87.47%	50,995 $3.81 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $1.72 Million - $2.58 Million	40,823 Added 11.15%	406,833 $25.7 Million
Q1 2019 May 07, 2019	BUY	$31.96 - $56.12 $648,276 - $1.14 Million	20,284 Added 5.87%	366,010 $17.6 Million
Q4 2018 Jan 25, 2019	BUY	$28.72 - $52.63 $7 Million - $12.8 Million	243,903 Added 239.54%	345,726 $11.6 Million
Q3 2018 Oct 30, 2018	SELL	$32.0 - $52.4 $8.13 Million - $13.3 Million	-254,144 Reduced 71.4%	101,823 $5.34 Million
Q2 2018 Aug 03, 2018	SELL	$19.85 - $32.0 $14.9 Million - $24.1 Million	-751,932 Reduced 67.87%	355,967 $11.1 Million
Q1 2018 Apr 30, 2018	BUY	$19.3 - $23.65 $501,819 - $614,923	26,001 Added 2.4%	1,107,899 $24.2 Million
Q4 2017 Jan 18, 2018	BUY	$16.3 - $21.9 $4.05 Million - $5.44 Million	248,322 Added 29.79%	1,081,898 $21.9 Million
Q3 2017 Oct 31, 2017	BUY	$18.05 - $21.75 $15 Million - $18.1 Million	833,576	833,576 $16.5 Million

Others Institutions Holding NVCR

# of Institutions

277

Shares Held

73.2M

Call Options Held

1.43M

Put Options Held

832K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.8B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Novo Cure LTD Transaction History